Renaud Du Pasquier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


145 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 | 1994 |
 
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
Santos GMA, Locatelli I., Métral M., Calmy A., Lecompte T.D., Nadin I., Hauser C., Cusini A., Hasse B., Kovari H. et al., 2019/07. Open forum infectious diseases, 6 (7) pp. ofz277. Peer-reviewed.
 
Motor behavior unmasks residual cognition in disorders of consciousness.
Pincherle A., Jöhr J., Chatelle C., Pignat J.M., Du Pasquier R., Ryvlin P., Oddo M., Diserens K., 2019/03. Annals of neurology, 85 (3) pp. 443-447. Peer-reviewed.
 
Neurologie [Neurology]
Eskioglou E., Benninger D., Di Virgilio G., Hirt L., Kuntzer T., Michel P., Novy J., Rossetti A.O., Rouaud O., Ryvlin P. et al., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 74-77. Peer-reviewed.
 
Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines.
Perriot S., Mathias A., Perriard G., Canales M., Jonkmans N., Merienne N., Meunier C., El Kassar L., Perrier A.L., Laplaud D.A. et al., 2018/11/13. Stem cell reports, 11 (5) pp. 1199-1210. Peer-reviewed.
Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T., Martenet S., Mamin R., Du Pasquier R.A., Peters S., Perreau M., Muller O., Hugli O., Cavassini M., Darling KEA, 2018/10/03. BMJ open, 8 (10) pp. e021203. Peer-reviewed.
 
Late Lyme neuroborreliosis with chronic encephalomyelitis.
Beuchat I., Dunet V., Meylan P., Du Pasquier R., 2018/09/25. Neurology, 91 (13) pp. 627-628. Peer-reviewed.
Exploring the effect of vitamin D<sub>3</sub> supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
Rolf L., Muris A.H., Mathias A., Du Pasquier R., Koneczny I., Disanto G., Kuhle J., Ramagopalan S., Damoiseaux J., Smolders J. et al., 2018/09. Multiple sclerosis, 24 (10) pp. 1280-1287. Peer-reviewed.
 
Mouvements anormaux
Burkhard P., Benninger D., Du Pasquier R., Kleinschmidt A., 2018/04/25. Revue medicale suisse, 14 (604) pp. 867-868. Peer-reviewed.
 
Wirksamkeit von Natalizumab bei intermediärer Uveitis bei Multipler Sklerose: ein Fallbericht [Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report]
Roemer S., Bissig A., Rocca A., Du Pasquier R., Guex-Crosier Y., 2018/04. Klinische Monatsblatter fur Augenheilkunde, 235 (4) pp. 476-477. Peer-reviewed.
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.
Hottinger A.F., de Micheli R., Guido V., Karampera A., Hagmann P., Du Pasquier R., 2018/03. Neurology, 5 (2) pp. e439. Peer-reviewed.
 
Neurologie [Neurology]
Chopard I., Benninger D., Demonet J.F., Du Pasquier R., Hirt L., Kuntzer T., Michel P., Nater B., Novy J., Rossetti A. et al., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 58-61. Peer-reviewed.
Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.
Perrotta G., Bonnier G., Meskaldji D.E., Romascano D., Aydarkhanov R., Daducci A., Simioni S., Cavassini M., Metral M., Lazeyras F. et al., 2017/12. Annals of clinical and translational neurology, 4 (12) pp. 915-920. Peer-reviewed.
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.
Mathias A., Perriot S., Canales M., Blatti C., Gaubicher C., Schluep M., Engelhardt B., Du Pasquier R., 2017/11. Neurology, 4 (6) pp. e401. Peer-reviewed.
The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
Merienne N., Vachey G., de Longprez L., Meunier C., Zimmer V., Perriard G., Canales M., Mathias A., Herrgott L., Beltraminelli T. et al., 2017/09/19. Cell reports, 20 (12) pp. 2980-2991. Peer-reviewed.
An unusual case of miliary PML-IRIS in an HIV+ patient.
Cuendet D., Sarro R., Merz L., Jiménez M.C., Maeder P., Du Pasquier R., Tsouni P., 2017/07. Neurology(R) neuroimmunology & neuroinflammation, 4 (4) pp. e370. Peer-reviewed.
 
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Mathias A., Perriard G., Canales M., Soneson C., Delorenzi M., Schluep M., Du Pasquier R.A., 2017/05. Multiple sclerosis, 23 (6) pp. 802-809. Peer-reviewed.
 
Organisation de la prise en charge des accidents vasculaires cérébraux en Suisse romande
Carrera E., Hirt L., Sztajzel R., Michel P., Kleinschmidt A., Du Pasquier R., 2017/04/26. Revue medicale suisse, 13 (560) pp. 883-884. Peer-reviewed.
 
The Evolution of Cortical and Sub-cortical Lesion Size and Number Correlates with Changes in Cognition in Early-Stage Relapsing-Remitting Multiple Sclerosis Patients
Sorega A., Fartaria MJ., Bonnier G., Kober T., Du Pasquier R., Schluep M., Krueger G., Bach Cuadra M., Granziera C., 2017/04/22. dans Proceedings of 25th Annual Meeting of Intl. Soc. Mag. Reson. Med (ISMRM). Peer-reviewed.
 
Evaluation de la plateforme Neuro-VIH d’un hôpital universitaire par les patients et les médecins traitants [Evaluation of an outpatient multidisciplinary Neuro-HIV clinic by the patients and referring doctors]
Vallotton K., Métral M., Chocron O., Meuli R., Alves D., Du Pasquier R., Cavassini M., 2017/04/12. Revue medicale suisse, 13 (558) pp. 782-786. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.
Bacchetta F., Mathias A., Schluep M., Du Pasquier R., 2017/02. Multiple sclerosis, 23 (2) pp. 300-303. Peer-reviewed.
 
Neurologie [Neurology]
Maulucci F., Benninger D., Démonet J.F., Du Pasquier R.A., Hirt L., Hottinger A., Kuntzer T., Michel P., Nater B., Novy J. et al., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 79-83. Peer-reviewed.
EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
Clottu A.S., Mathias A., Sailer A.W., Schluep M., Seebach J.D., Du Pasquier R., Pot C., 2017/01/03. Cell reports, 18 (1) pp. 213-224. Peer-reviewed.
The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.
Bonnier G., Maréchal B., Fartaria M.J., Falkowskiy P., Marques J.P., Simioni S., Schluep M., Du Pasquier R., Thiran J.P., Krueger G. et al., 2017. Frontiers in neurology, 8 p. 506. Peer-reviewed.
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
Kamal S., Locatelli I., Wandeler G., Sehhat A., Bugnon O., Metral M., Du Pasquier R., Gutbrod K., Cavassini M., Schneider M.P. et al., 2017. Open forum infectious diseases, 4 (2) pp. ofx070. Peer-reviewed.
 
In memoriam Christian Wider, MD 1973-2016.
Ross O.A., Du Pasquier R., 2016/12. Parkinsonism & related disorders, 33 pp. 1-2. Peer-reviewed.
 
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.
Marignier R., Durand-Dubief F., du Pasquier R., Vukusic S., 2016/11. Annals of neurology, 80 (5) p. 791. Peer-reviewed.
 
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Kuhle J., Barro C., Disanto G., Mathias A., Soneson C., Bonnier G., Yaldizli Ö., Regeniter A., Derfuss T., Canales M. et al., 2016/10. Multiple sclerosis, 22 (12) pp. 1550-1559. Peer-reviewed.
 
Clinical Reasoning: An 82-year-old woman with dissociated aphasia followed by amnesia.
Eskioglou E., Du Pasquier R.A., Rossetti A.O., Sokolov A.A., 2016/08/30. Neurology, 87 (9) pp. e91-6. Peer-reviewed.
 
PML risk stratification using anti-JCV antibody index and L-selectin.
Schwab N., Schneider-Hohendorf T., Pignolet B., Spadaro M., Görlich D., Meinl I., Windhagen S., Tackenberg B., Breuer J., Cantó E. et al., 2016/07. Multiple sclerosis, 22 (8) pp. 1048-1060. Peer-reviewed.
 
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
Fartaria M.J., Bonnier G., Roche A., Kober T., Meuli R., Rotzinger D., Frackowiak R., Schluep M., Du Pasquier R., Thiran J.P. et al., 2016/06. Journal of magnetic resonance imaging, 43 (6) pp. 1445-1454. Peer-reviewed.
 
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Spatola M., Du Pasquier R., Schluep M., Regeniter A., 2016/05/10. Neurology, 86 (19) pp. 1780-1784. Peer-reviewed.
 
Longitudinal Automated Detection of White-Matter and Cortical Lesions in Relapsing-Remitting Multiple Sclerosis
Fartaria MJ., Bonnier G., Kober T., Roche A., Maréchal B., Rotzinger D., Schluep M., Du Pasquier R., Thiran JP., Krueger G. et al., 2016/05/07. dans 24th Proc. Intl. Soc. Mag. Reson. Med. Peer-reviewed.
Longitudinal automated detection of white-matter and cortical lesions in relapsing-remitting multiple sclerosis
Fartaria de Oliveira MJ. , Bonnier G., Kober T., Roche A., Maréchal B., Rotzinger D., Schluep M., Du Pasquier R., Thiran JP., Krueger G. et al., 2016/05. dans ISMRM 2016 , ISMRM 24rd Annual Meeting & Exhibition, SMRT 25th Annual Meeting. Peer-reviewed.
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
Bonnier G., Kober T., Schluep M., Du Pasquier R., Krueger G., Meuli R., Granziera C., Roche A., 2016. Plos One, 11 (2) pp. e0148631. Peer-reviewed.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Disanto G., Benkert P., Lorscheider J., Mueller S., Vehoff J., Zecca C., Ramseier S., Achtnichts L., Findling O., Nedeltchev K. et al., 2016. Plos One, 11 (3) pp. e0152347. Peer-reviewed.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Mathias A., Perriard G., Canales M., Vuilleumier F., Perrotta G., Schluep M., Du Pasquier R., 2016. Neurology: Neuroimmunology & Neuroinflammation, 3 (2) pp. e209. Peer-reviewed.
 
Exploration of advanced MR imaging contrasts for automated detection of white matter and cortical lesions in early-stages of multiple sclerosis
Fartaria Mario Joao, Bonnier Guillaume, Roche Alexis, Kober Tobias, Meuli Reto, Rotzinger David, Schluep Myriam, Du Pasquier Renaud, Thiran Jean-Philippe, Krueger Gunnar et al., 2015/05/30. dans Proceedings of 23th Annual Meeting of ISMRM. Peer-reviewed.
 
Establishment of a multi-disciplinary platform for HIV-infected patients with neurological complications.
du Pasquier R., Simioni S., Alves D., Meuli R., Maccaferri G.E., Berney A., Cavassini M., 2015/04/08. p. 88 dans Scientific Abstract Listing of the 66th Annual Meeting, , Neurology. Peer-reviewed, American Academy of Neurology (AAN).
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
 
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Derfuss T., Curtin F., Guebelin C., Bridel C., Rasenack M., Matthey A., Du Pasquier R., Schluep M., Desmeules J., Lang A.B. et al., 2015. Multiple Sclerosis, 21 (7) pp. 885-893. Peer-reviewed.
 
Acute Lyme Neuroborreliosis With Transient Hemiparesis and Aphasia.
Sokolov A.A., Lienhard R., Du Pasquier R., Erard V., 2015. Annals of Emergency Medicine, 66 (1) pp. 60-64. Peer-reviewed.
 
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.
Giulieri S., Chapuis-Taillard C., Jaton K., Cometta A., Chuard C., Hugli O., Du Pasquier R., Bille J., Meylan P., Manuel O. et al., 2015. European Journal of Clinical Microbiology and Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 34 (10) pp. 2049-2055. Peer-reviewed.
 
Environmental factors in multiple sclerosis [Environmental factors in multiple sclerosis]
Pantazou V., Schluep M., Du Pasquier R., 2015. Presse Medicale, 44 (4 Pt 2) pp. e113-e120. Peer-reviewed.
 
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Perriard G., Mathias A., Enz L., Canales M., Schluep M., Gentner M., Schaeren-Wiemers N., Du Pasquier R.A., 2015. Journal of Neuroinflammation, 12 p. 119. Peer-reviewed.
 
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Parfenov V., Du Pasquier R., Schluep M., 2015. Neurologist, 19 (6) pp. 155-157. Peer-reviewed.
 
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Lalive P.H., Bridel C., Ferfoglia R.I., Kaiser L., Du Pasquier R., Barkhof F., Haller S., 2015. Journal of Neurology, Neurosurgery, and Psychiatry, 86 (3) pp. 354-355. Peer-reviewed.
 
Multicontrast connectometry: A new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis.
Romascano D., Meskaldji D.E., Bonnier G., Simioni S., Rotzinger D., Lin Y.C., Menegaz G., Roche A., Schluep M., Pasquier R.D. et al., 2015. Human Brain Mapping, 36 (4) pp. 1609-1619. Peer-reviewed.
 
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Bonnier G., Roche A., Romascano D., Simioni S., Meskaldji D.E., Rotzinger D., Lin Y.C., Menegaz G., Schluep M., Du Pasquier R. et al., 2015. Biomed Research International, 2015 p. 569123. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
Kurmann R., Weisstanner C., Kardas P., Hirsch H.H., Wiest R., Lämmle B., Furrer H., Du Pasquier R., Bassetti C.L., Sturzenegger M. et al., 2015. Journal of Neurovirology, 21 (6) pp. 694-701. Peer-reviewed.
 
Relapse in herpes simplex virus encephalitis: It's not just about the virus.
Bale J.F., Du Pasquier R., 2015. Neurology, 85 (20) pp. 1730-1731. Peer-reviewed.
Status epilepticus of inflammatory etiology: A cohort study.
Spatola M., Novy J., Du Pasquier R., Dalmau J., Rossetti A.O., 2015. Neurology, 85 (5) pp. 464-470. Peer-reviewed.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Bonnier G., Roche A., Romascano D., Simioni S., Meskaldji D., Rotzinger D., Lin Y.C., Menegaz G., Schluep M., Du Pasquier R. et al., 2014/06. Annals of Clinical and Translational Neurology, 1 (6) pp. 423-432. Peer-reviewed.
 
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Jilek S., Mathias A., Canales M., Lysandropoulos A., Pantaleo G., Schluep M., Du Pasquier R.A., 2014/06. Multiple sclerosis (Houndmills, Basingstoke, England), 20 (7) pp. 837-842. Peer-reviewed.
 
Immune system's role in viral encephalitis.
Spatola M., Du Pasquier R.A., 2014. Revue Neurologique, 170 (10) pp. 577-583. Peer-reviewed.
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.
Du Pasquier R.A., Pinschewer D.D., Merkler D., 2014. Cns Drugs, 28 (6) pp. 535-558. Peer-reviewed.
 
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
Simioni S., Amarù F., Bonnier G., Kober T., Rotzinger D., Du Pasquier R., Schluep M., Meuli R., Sbarbati A., Thiran J.P. et al., 2014. Journal of Neurology, 261 (8) pp. 1606-1613.
 
Multicontrats MRI Improved the Clinico-Radiological Correlation in Early Multiple Sclerosis Patients with Minor Deficits
Bonnier Guillaume, Roche Alexis, Romascano David, Simioni Samanta, Meskaldji Djalel Eddine, Rotzinger David, Lin Ying-Chia, Menegaz Gloria, Schluep Myriam, Du Pasquier Renaud et al., 2014. dans 22nd annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM).
 
Multiple Sclerosis Lesion Fingerprint Using Multicontrast MRI
Bonnier Guillaume, Roche Alexis, Romascano David, Simioni Samanta, Meskaldji Djalel Eddine, Rotzinger David, Lin Ying-Chia, Menegaz Gloria, Schluep Myriam, Du Pasquier Renaud et al., 2014. dans 22nd annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM).
 
Neurologie [News in neurology 2013].
Spatola M., Rossetti A.O., Michel P., Kuntzer T., Benninger D., Nater B., Démonet J.F., Schluep M., Du Pasquier R.A., Vingerhoets F., 2014. Revue Médicale Suisse, 10 (412-413) pp. 78-81. Peer-reviewed.
 
Réplication cérébrale du VIH malgré une thérapie antirétrovirale efficace: impact clinique et prise en charge [Intracerebral HIV replication despite an efficient antiretroviral treatment: clinical impact and management].
Schibler M., Calmy A., Cavassini M., Du Pasquier R., 2014. Revue Médicale Suisse, 10 (427) pp. 908, 910-908, 912. Peer-reviewed.
 
A light in the cognitive fog?
Cavassini M., Du Pasquier R.A., 2013. Antiviral Therapy, 18 (2) pp. 149-151. Peer-reviewed.
 
Anticorps antineuronaux: un domaine en plein développement [Anti-neuronal antibodies: a rapidly developing field].
Zekeridou A., Rossetti A.O., Hottinger A.F., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 909-914.
 
Assessing risks of multiple sclerosis therapies.
Parfenov V., Schluep M., Du Pasquier R., 2013. Journal of the Neurological Sciences, 332 (1-2) pp. 59-65. Peer-reviewed.
 
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
Zahednasab H., 2013. Neurology, 81 (1) pp. 97-98.
 
Maladies auto-immunes neuromusculaires: diagnostic et prise en charge [Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management].
Lalive P.H., Du Pasquier R.A., Chizzolini C., Kuntzer T., 2013. Revue Médicale Suisse, 9 (384) pp. 934-939. Peer-reviewed.
 
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy.
Du Pasquier R.A., Jilek S., Kalubi M., Yerly S., Fux C.A., Gutmann C., Cusini A., Günthard H.F., Cavassini M., Vernazza P.L. et al., 2013. Aids, 27 (2) pp. 203-210. Peer-reviewed.
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
Granziera C., Daducci A., Simioni S., Cavassini M., Roche A., Meskaldji D., Kober T., Metral M., Calmy A., Helms G. et al., 2013. Plos One, 8 (9) pp. e72547.
 
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Jilek S., Schluep M., Pantaleo G., Du Pasquier R.A., 2013. Neurological Sciences, 34 (4) pp. 539-543.
 
Neurologie [2012: news in neurology].
Alvarez V., Rossetti A.O., Michel P., Kuntzer T., Nater B., Démonet J.F., Schluep M., Du Pasquier R., Vingerhoets F., 2013. Revue Médicale Suisse, 9 (368) pp. 62-65. Peer-reviewed.
 
On s'enflamme tous pour la tête [Head inflammation].
Du Pasquier R.A., Lalive P.H., 2013. Revue Médicale Suisse, 9 (384) p. 907.
 
Reply to the letter of Zahednasab H. in Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
Du Pasquier R.A., Canales M., Schluep M., 2013. Neurology, 81 (1) p. 98. Peer-reviewed.
 
Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study.
Simioni S., Cavassini M., Annoni J.M., Métral M., Iglesias K., Rimbault Abraham A., Jilek S., Calmy A., Müller H., Fayet-Mello A. et al., 2013. Neurology, 80 (6) pp. 553-560.
 
Traitement de tla sclérose en plaques: nouveautés et complications [New treatment options in multiple sclerosis and their complications].
Schluep M., Lalive P.H., Du Pasquier R.A., 2013. Revue Médicale Suisse, 9 (384) pp. 940-943.
 
Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control.
Schwab N., Ulzheimer J.C., Fox R.J., Schneider-Hohendorf T., Kieseier B.C., Monoranu C.M., Staugaitis S.M., Welch W., Jilek S., Du Pasquier R.A. et al., 2012. Neurology, 78 (7) pp. 458-467. Peer-reviewed.
HIV Testing Practices by Clinical Service before and after Revised Testing Guidelines in a Swiss University Hospital.
Darling K.E., Hugli O., Mamin R., Cellerai C., Martenet S., Berney A., Peters S., Du Pasquier R.A., Bodenmann P., Cavassini M., 2012. Plos One, 7 (6) pp. e39299. Peer-reviewed.
 
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Jilek S., Schluep M., Harari A., Canales M., Lysandropoulos A., Zekeridou A., Pantaleo G., Du Pasquier R.A., 2012. Journal of Immunology, 188 (9) pp. 4671-4680. Peer-reviewed.
 
Immunological and clinical consequences of treating a patient with natalizumab.
Schwab N., Höhn K.G., Schneider-Hohendorf T., Metz I., Stenner M.P., Jilek S., Du Pasquier R.A., Gold R., Meuth S.G., Ransohoff R.M. et al., 2012. Multiple Sclerosis, 18 (3) pp. 335-344. Peer-reviewed.
 
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Antoniol C., Jilek S., Schluep M., Mercier N., Canales M., Le Goff G., Campiche C., Pantaleo G., Du Pasquier R.A., 2012. Neurology, 79 (23) pp. 2258-2264.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Simioni S., Schluep M., Bault N., Coricelli G., Kleeberg J., Du Pasquier R.A., Gschwind M., Vuilleumier P., Annoni J.M., 2012. Plos One, 7 (12) pp. e50718. Peer-reviewed.
 
Neurologie [Neurology].
Chabwine J.N., Rossetti A.R., Hirt L., Kuntzer T., Schluep M., Michel P., Démonet J.F., du Pasquier R.A., Vingerhoets F.G., 2012. Revue Médicale Suisse, 8 (323) pp. 46-50. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia
Silva M., Chabwine J. N., Lhermitte B., Buss G., Maeder P., Du Pasquier R. A., 2012. p. 748 dans 16th Congress of the European-Federation-of-Neurological-Societies (EFNS), European Journal of Neurology.
 
Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia.
Chabwine J.N., Lhermitte B., Da Silva M.O., Buss G., Maeder P., Du Pasquier R.A., 2012. Neurology, 78 (24) pp. 2000-2002.
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.
Stravodimou A., Cairoli A., Rausch T., Du Pasquier R., Michel P., 2012. Case Reports In Medicine, 2012 p. 239719.
 
Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
Schluep M., Du Pasquier R., 2012. Revue Médicale Suisse, 8 (339) pp. 946-949.
 
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Ludigs K., Parfenov V., Du Pasquier R.A., Guarda G., 2012. Cellular and Molecular Life Sciences, 69 (20) pp. 3395-3418. Peer-reviewed.
 
Effect of vitamin D on EBV-specific CD8+T cells in patients with early multiple sclerosis
Lysandropoulos A., Schluep M., Jaquiery E., Jilek S., Canales M., Pantaleo G., Du Pasquier R., 2011. p. 117 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
 
Exploration of immune competencies of viral-specific CD8+T cells in MS patients using tetramers and functional CTL assays
Jilek S., Lysandropoulos A., Zekeridou A., Canales M., Schluep M., Pantaelo G., Du Pasquier R., 2011. p. 117 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
HIV-associated neurocognitive disorders (HAND): a changing pattern
Simioni S., Cavassini M., Annoni J.M., Hirschel B., Du Pasquier R.A., 2011. Future Neurology, 6 (1) pp. 81-95. Peer-reviewed.
 
Neurologie [Therapeutic advances in neurology].
Siclari F., Du Pasquier R.A., Schluep M., Michel P., Hirt L., Kuntzer T., Rossetti A.O., Ghika J., Nater B., Vingerhoets F.J., 2011. Revue Médicale Suisse, 7 (277) pp. 50-56. Peer-reviewed.
Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
Kuntzer T., Carota A., Novy J., Cavassini M., Du Pasquier R.A., 2011. Neurology, 76 (8) pp. 757-758. Peer-reviewed.
 
Type I interferon inhibits interleukin-1 production and inflammasome activation.
Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R.A., Romero P. et al., 2011. Immunity, 34 (2) pp. 213-223. Peer-reviewed.
 
Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
Lysandropoulos A.P., Jaquiéry E., Jilek S., Pantaleo G., Schluep M., Du Pasquier R.A., 2011. Journal of Neuroimmunology, 233 (1-2) pp. 240-244. Peer-reviewed.
 
A promenade along the stream of demyelination.
Du Pasquier R.A., 2010. Current Opinion In Neurology, 23 (3) pp. 203-204. Peer-reviewed.
 
Attaques cérébrovasculaires ischémiques multiples dues à une méningovasculite à Borrelia garinii. [Multiple ischemic strokes due to Borrelia garinii meningovasculitis].
Rey V., Du Pasquier R., Muehl A., Péter O., Michel P., 2010. Revue Neurologique, 166 (11) pp. 931-934. Peer-reviewed.
 
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
Simioni S., Cavassini M., Annoni J.M., Rimbault Abraham A., Bourquin I., Schiffer V., Calmy A., Chave J.P., Giacobini E., Hirschel B. et al., 2010. Aids, 24 (9) pp. 1243-1250. Peer-reviewed.
 
Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study.
Jaquiéry E., Jilek S., Schluep M., Le Goff G., Garcia M., Pantaleo G., Du Pasquier R.A., 2010. Journal of Neuroimmunology, 225 (1-2) pp. 167-170. Peer-reviewed.
 
Demyelination as a complication of new immunomodulatory treatments.
Lysandropoulos A.P., Du Pasquier R.A., 2010. Current Opinion In Neurology, 23 (3) pp. 226-233. Peer-reviewed.
 
EFNS guidelines on diagnosis and management of neuromyelitis optica.
Sellner J., Boggild M., Clanet M., Hintzen R.Q., Illes Z., Montalban X., Du Pasquier R.A., Polman C.H., Sorensen P.S., Hemmer B., 2010. European Journal of Neurology, 17 (8) pp. 1019-1032. Peer-reviewed.
 
Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A. et al., 2010. Journal of Clinical Investigation, 120 (3) pp. 713-719. Peer-reviewed.
 
Imaging Properties of MS Lesions Correlate with Attention Deficits in Early Multiple Sclerosis
Simioni S., Kober T., Krueger G., Shevlyakova M., Browaeys P., Annoni J.M., Du Pasquier R., Meuli R., Schluep M., Granziera C., 2010. dans OHBM 2010, 16th Annual Meeting of the Organization for Human Brain Mapping.
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Jilek S., Jaquiéry E., Hirsch H.H., Lysandropoulos A., Canales M., Guignard L., Schluep M., Pantaleo G., Du Pasquier R.A., 2010. Lancet Neurology, 9 (3) pp. 264-272. Peer-reviewed.
 
Intrathecal immune responses to EBV in early MS.
Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G., Du Pasquier R.A., 2010. European Journal of Immunology, 40 (3) pp. 878-887. Peer-reviewed.
 
Autoanticorps en neurologie: implications cliniques [Autoantibodies in neurological diseases: clinical implications]
Lalive P.H., Chofflon M., Du Pasquier R.A., Burkhard P.R., 2009. Revue Médicale Suisse, 5 (201) pp. 942-944, 946-948, 950.
 
Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
Novy J., Carota A., Eggimann P., Pusztaszeri M., Rossetti A.O., Du Pasquier R., 2009. BMJ case reports, 2009 pp. 11 August. Peer-reviewed.
 
Encéphalites virales [Viral encephalitis: update]
Du Pasquier R., Meylan P., Kaiser L., Lalive P.H., 2009. Revue Médicale Suisse, 5 (201) pp. 968-970, 972-973.
 
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N., Wolbers M., Mueller N.J., Garzoni C., Du Pasquier R.A., Fux C.A., Vernazza P., Bernasconi E., Viscidi R., Battegay M. et al., 2009. Journal of Virology, 83 (9) pp. 4404-4411. Peer-reviewed.
 
Neurologie [Therapeutic advances in neurology].
Morier J., Du Pasquier R., Kuntzer T., Michel P., Nater B., Niederhauser J., Rossetti A.O., Schluep M., Vingerhoets F., 2009. Revue Médicale Suisse, 5 (185) pp. 39-48. Peer-reviewed.
 
Nouveau spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapies [New spectrum of HIV-associated cognitive disorders in the HAART era]
Du Pasquier R., Cavassini M., Simioni S., Annoni J.M., Giacobini E., Hirschel B., 2009. Revue Médicale Suisse, 5 (201) pp. 955-956, 958-961.
 
Progressive decline of decision-making performances during multiple sclerosis.
Simioni S., Ruffieux C., Kleeberg J., Bruggimann L., du Pasquier R.A., Annoni J.M., Schluep M., 2009. Journal of the International Neuropsychological Society, 15 (2) pp. 291-295. Peer-reviewed.
 
Inaugural description of Cogan syndrome in an HIV-infected person.
Kleeberg J., Maire R., Chave J.P., Pournaras J.A., Guex-Crosier Y., Du Pasquier R.A., 2008. Journal of neurology, 255 (9) pp. 1427-8. Peer-reviewed.
 
Neurologie [Neurology]
Cereda C., Du Pasquier R., 2008. Revue Médicale Suisse, 4 (139) pp. 49-56.
 
Neuropsychiatrie [Neuropsychiatry].
Burkhard P.R., Vingerhoets F.J., Landis T., Du Pasquier R.A., 2008. Revue Médicale Suisse, 4 (156) pp. 1131-1132.
 
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G., Du Pasquier R.A., 2008. Brain, 131 (Pt 7) pp. 1712-1721. Peer-reviewed.
 
Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.
Jilek S., Kuhle J., Meylan P., Reichhart M.D., Pantaleo G., Du Pasquier R.A., 2007/10. Journal of Neuroimmunology, 192 (1-2) pp. 192-197. Peer-reviewed.
 
Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids.
Deruaz C.A., Spertini F., Souza Lima F., Du Pasquier R.A., Schluep M., 2007. Multiple Sclerosis, 13 (4) pp. 559-560. Peer-reviewed.
 
Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
Yang W., Beaudoin E.L., Lu L., Du Pasquier R.A., Kuroda M.J., Willemsen R.A., Koralnik I.J., Junghans R.P., 2007. International Immunology, 19 (9) pp. 1083-1093. Peer-reviewed.
 
CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Jilek S., Schluep M., Rossetti A.O., Guignard L., Le Goff G., Pantaleo G., Du Pasquier R.A., 2007. Clinical Immunology, 123 (1) pp. 105-113. Peer-reviewed.
 
Limbic encephalitis: another example of molecular mimicry?
Du Pasquier R., 2007. European Neurology, 57 (4) pp. 191-192. Peer-reviewed.
 
Neurologie [Neurology]
Botez S., Carota A., Dunand M., Du Pasquier R., Kuntzer T., Michel P., Morier J., Schluep M., Rossetti A.O., 2007. Revue Médicale Suisse, 3 (93) pp. 39-47. Peer-reviewed.
 
Neuromyelitis optica following CMV primo-infection.
Tran C., Du Pasquier R.A., Cavassini M., Guex-Crosier Y., Meuli R., Ciuffreda D., Waeber G., 2007. Journal of Internal Medicine, 261 (5) pp. 500-503. Peer-reviewed.
 
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.
Vulliemoz S., Lurati-Ruiz F., Borruat F.X., Delavelle J., Koralnik I.J., Kuntzer T., Bogousslavsky J., Picard F., Landis T., Du Pasquier R.A., 2006/09. Journal of Neurology, 77 (9) pp. 1079-1082. Peer-reviewed.
 
Immunite et neurodegenerescence: nouveaux concepts dans la sclerose en plaques. [Immunity and neurodegeneration: new concepts in multiple sclerosis]
Lalive P. H., Schluep M., Chofflon M., Du Pasquier R., 2006/05. Revue Médicale Suisse, 2 (64) pp. 1166-8, 1170.
 
Functional signatures of protective antiviral T-cell immunity in human virus infections.
Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., Pantaleo G., 2006. Immunological Reviews, 211 pp. 236-254. Peer-reviewed.
 
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y., Trofe J., Gordon J., Du Pasquier R.A., Roy-Chaudhury P., Kuroda M.J., Woodle E.S., Khalili K., Koralnik I.J., 2006. Journal of Virology, 80 (7) pp. 3495-3505. Peer-reviewed.
 
JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients.
Du Pasquier R.A., Stein M.C., Lima M.A., Dang X., Jean-Jacques J., Zheng Y., Letvin N.L., Koralnik I.J., 2006. Journal of Neuroimmunology, 176 (1-2) pp. 181-186. Peer-reviewed.
 
Neurologie. [Therapeutical advances in neurology in 2005]
Du Pasquier R., Bogousslavsky J., 2006/01. Revue Médicale Suisse, 2 (47) pp. 35-40.
 
Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
Du Pasquier R.A., Autissier P., Zheng Y., Jean-Jacques J., Koralnik I.J., 2005. Aids, 19 (18) pp. 2069-2076. Peer-reviewed.
 
Traitements immunomodulateurs/ suppresseurs en neurologie. [Immunomodulatory/suppressive treatments in neurology]
Schluep M., Chofflon M., Kuntzer T., Du Pasquier R., 2005. Revue Médicale Suisse, 1 (18) pp. 1229-1232. Peer-reviewed.
 
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., Koralnik I.J., 2004/09. Brain, 127 (Pt 9) pp. 1970-1978. Peer-reviewed.
 
Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.
Du Pasquier R.A., Schmitz J.E., Jean-Jacques J., Zheng Y., Gordon J., Khalili K., Letvin N.L., Koralnik I.J., 2004. Journal of Virology, 78 (18) pp. 10206-10210. Peer-reviewed.
 
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
Katz-Brull R., Lenkinski R.E., Du Pasquier R.A., Koralnik I.J., 2004. Neurology, 63 (5) pp. 897-900. Peer-reviewed.
 
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual.
Du Pasquier R.A., Corey S., Margolin D.H., Williams K., Pfister L.A., De Girolami U., Mac Key J.J., Wüthrich C., Joseph J.T., Koralnik I.J., 2003/09. Neurology, 61 (6) pp. 775-782. Peer-reviewed.
 
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.
Burkhard P.R., Delavelle J., Du Pasquier R., Spahr L., 2003. Archives of Neurology, 60 (4) pp. 521-528. Peer-reviewed.
 
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?
Du Pasquier R.A., Koralnik I.J., 2003. Journal of Neurovirology, 9 (Suppl. 1) pp. 25-31. Peer-reviewed.
 
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Zheng Y., Martin K., Peyerl F.W., Lifton M., Gorgone D., Autissier P., Letvin N.L. et al., 2003. Journal of Virology, 77 (22) pp. 11918-11926. Peer-reviewed.
 
The effect of aging on postural stability: a cross sectional and longitudinal study.
Du Pasquier R.A., Blanc Y., Sinnreich M., Landis T., Burkhard P., Vingerhoets F.J., 2003. Neurophysiologie Clinique = Clinical Neurophysiology, 33 (5) pp. 213-218. Peer-reviewed.
 
Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik I.J., Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Dang X., Zheng Y., Lifton M., Letvin N.L., 2002. Journal of Immunology, 168 (1) pp. 499-504. Peer-reviewed.
 
Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes.
Lazeyras F., Spahr L., DuPasquier R., Delavelle J., Burkhard P., Hadengue A., Hochstrasser D., Mentha G., Giostra E., Terrier F. et al., 2002. Transplant International, 15 (4) pp. 188-195. Peer-reviewed.
 
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik I.J., Du Pasquier R.A., Letvin N.L., 2001. Journal of Virology, 75 (7) pp. 3483-3487. Peer-reviewed.
 
JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
Du Pasquier R.A., Clark K.W., Smith P.S., Joseph J.T., Mazullo J.M., De Girolami U., Letvin N.L., Koralnik I.J., 2001. Journal of Neurovirology, 7 (4) pp. 318-322. Peer-reviewed.
 
Monocular central dazzle after thalamic infarcts.
Du Pasquier R.A., Genoud D., Safran A.B., Landis T., 2000/06. Journal of Neuro-ophthalmology, 20 (2) pp. 97-99. Peer-reviewed.
 
Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.
Spahr L., Vingerhoets F., Lazeyras F., Delavelle J., DuPasquier R., Giostra E., Mentha G., Terrier F., Hadengue A., 2000. Gastroenterology, 119 (3) pp. 774-781. Peer-reviewed.
 
Severe but reversible encephalopathy associated with cefepime.
Jallon P., Fankhauser L., Du Pasquier R., Coeytaux A., Picard F., Hefft S., Assal F., 2000. Neurophysiologie Clinique = Clinical Neurophysiology, 30 (6) pp. 383-386. Peer-reviewed.
 
Periodic downbeat nystagmus.
Du Pasquier R., Vingerhoets F., Safran A.B., Landis T., 1998/11. Neurology, 51 (5) pp. 1478-1480. Peer-reviewed.
 
Atteinte du nerf lingual après extraction dentaire [Lesion of the lingual nerve after tooth extraction].
Du Pasquier R., Estade M., 1994. Revue Neurologique, 150 (5) pp. 393-395.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University